Home » GSK

GSK

Mar 23, 2017

GlaxoSmithKline, Regeneron Partner to Sequence Entire UK Biobank

The firms will have exclusive access for a limited time to the data from the first 50,000 individuals with samples in the biobank to be sequenced.

Feb 08, 2017

Penn Medicine Gets $3M From Pharma Consortium for Diabetic Kidney Disease Study

The study seeks to identify biomarkers that can help personalize treatment for patients by identifying signs of rapid decline in kidney function.

Aug 01, 2016

It's Electric

GlaxoSmithKline and Verily Life Sciences form Galvani Bioelectronics.

Jun 20, 2016

Drug and Diagnostic Industries Warm to Sharing Genomic Data, With Some Caveats and Challenges

Premium

Drug developers and genetic testing firms are contemplating how best to share variant classification data while protecting their commercial interests.

Jan 21, 2016

Case of Stolen Trade Secrets

Five people have been indicted for stealing trade secrets from GlaxoSmithKline, the Wall Street Journal reports.

Jun 29, 2015

Study Shows Genetic Support for Drug Targets Could Double Clinical Development Success Rate

Therapies aimed at drug targets that have been linked genetically to disease fare better through the drug development pipeline, researchers from GSK and elsewhere found.

Jun 17, 2015

GSK Invests $95M to Launch Institute Researching Gene Regulation for Rx Discovery, Development

The institute will develop new technologies and approaches to decode how genes are controlled and how a cell's "operating system" functions. 

Oct 08, 2014

GE/Clarient Setting Up Lab Network, Database to Advance Personalized Rx for GSK, Other Pharmas

Premium

Originally published Oct. 3.

Oct 03, 2014

GSK-led Team Develops Mass Spec Thermal Profiling Method for Studying Protein-Drug Interactions

Premium

NEW YORK (GenomeWeb) – A team led by researchers at Cellzome, a part of GlaxoSmithKline's R&D division, has developed a thermal profiling-based method for identifying protein drug targets and measuring protein-drug binding.

Oct 01, 2014

Phase III Studies Show Benefit of MEK/BRAF Inhibition in BRAF Mutated Melanoma Patients

Premium

Originally published Sept. 30.

Pages

The Scan

Try the Other Version

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

You Do Your Way

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

CRISPR Discussions

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

This Week in Science

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.

Sponsorships

Privacy Policy.  Copyright © 2017 GenomeWeb LLC.  All Rights Reserved.